Home > Boards > US Listed > Medical - Equipment > Neovasc, Inc. (NVCN)

The only scenario that I can conceive why

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Crapola2theleft Member Profile
 
Followed By 8
Posts 1,056
Boards Moderated 0
Alias Born 03/11/13
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/28/2020 2:12:18 PM
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducerâ„¢ Medical Device for the Treatment of Refractory Angina GlobeNewswire Inc. - 10/28/2020 7:00:10 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/22/2020 9:01:01 AM
Neovasc to Report Third Quarter Financial Results on November 5, 2020 GlobeNewswire Inc. - 10/22/2020 9:00:10 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/13/2020 8:04:22 AM
Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020 GlobeNewswire Inc. - 10/13/2020 8:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/25/2020 6:04:35 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/15/2020 6:18:58 AM
Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/8/2020 5:00:10 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/3/2020 5:12:44 PM
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders GlobeNewswire Inc. - 9/3/2020 4:34:09 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/20/2020 5:11:39 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/17/2020 9:01:21 AM
Neovasc Announces Partial Prepayment of Convertible Debenture GlobeNewswire Inc. - 8/17/2020 9:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2020 5:23:41 PM
Neovasc Provides Corporate Update GlobeNewswire Inc. - 8/13/2020 9:00:10 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 8/13/2020 6:09:21 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/12/2020 4:28:21 PM
Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market GlobeNewswire Inc. - 8/12/2020 2:25:56 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/10/2020 2:55:23 PM
Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 8/10/2020 8:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/10/2020 6:14:41 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/6/2020 4:16:34 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/6/2020 4:10:09 PM
Neovasc Announces Second Quarter Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Crapola2theleft   Tuesday, 04/21/20 03:47:24 PM
Re: None
Post # of 11847 
The only scenario that I can conceive why NVCN has not been approve of by the FDA is Fred telling them to hold off of the green light.

Other countries have had excellent results.

The FDA told NVCN the improvements they needed too make. They did.
Then the FDA told them to reapply. They did.

If FDA, approves now the buy out offers will be very low compare to after the economy improves. IMO.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences